Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae Type b Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00362427
What this trial is testing

Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®

Who this might be right for
DiphtheriaPertussisPolio+2 more
Sanofi Pasteur, a Sanofi Company 460
Large-scale testing (Phase 3)Study completedNCT01086423
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Who this might be right for
TetanusPoliomyelitisAcellular Pertussis+2 more
GlaxoSmithKline 985
Post-approval studies (Phase 4)Study completedNCT01457547
What this trial is testing

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

Who this might be right for
Hepatitis BPoliomyelitisDiphtheria+3 more
GlaxoSmithKline 494
Testing effectiveness (Phase 2)Study completedNCT00135486
What this trial is testing

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Large-scale testing (Phase 3)Study completedNCT01553279
What this trial is testing

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
MCM Vaccines B.V. 284
Large-scale testing (Phase 3)Study completedNCT00344318
What this trial is testing

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 806
Large-scale testing (Phase 3)Study completedNCT00880477
What this trial is testing

Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 140
Large-scale testing (Phase 3)Study completedNCT01214889
What this trial is testing

Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi 370
Large-scale testing (Phase 3)Study completedNCT00654901
What this trial is testing

Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 881
Large-scale testing (Phase 3)Study completedNCT00362336
What this trial is testing

Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV

Who this might be right for
Hepatitis BPolioDiphtheria+2 more
Sanofi Pasteur, a Sanofi Company 622
Post-approval studies (Phase 4)Study completedNCT01357720
What this trial is testing

Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 400
Testing effectiveness (Phase 2)Study completedNCT00129129
What this trial is testing

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 756
Testing effectiveness (Phase 2)Study completedNCT00289185
What this trial is testing

Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 340
Large-scale testing (Phase 3)Study completedNCT00441012
What this trial is testing

Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)

Who this might be right for
Haemophilus Influenzae Type BHepatitis B
Merck Sharp & Dohme LLC 546
Post-approval studies (Phase 4)Study completedNCT01896596
What this trial is testing

Hepatitis B Vaccination in Infants

Who this might be right for
Meningococcal DiseasePneumococcal DiseaseHaemophilus Influenzae Serotype b Disease+2 more
Public Health England 300
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Not applicableStudy completedNCT01878435
What this trial is testing

Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Johns Hopkins Bloomberg School of Public Health 2,018
Not applicableStudy completedNCT00855855
What this trial is testing

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

Who this might be right for
Haemophilus InfectionsDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 20,830
Large-scale testing (Phase 3)Study completedNCT00814710
What this trial is testing

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae
GlaxoSmithKline 360
Large-scale testing (Phase 3)Study completedNCT00453570
What this trial is testing

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Who this might be right for
DiphtheriaTetanusHaemophilus Influenzae Type b+2 more
Sanofi 792
Next Page